Tech Company Financing Transactions
Meritage Pharma Funding Round
On 6/16/2008, Meritage Pharma raised $22.5 million in Series A financing from Domain Associates, Latterell Venture Partners and The Vertical Group.
Transaction Overview
Company Name
Announced On
6/16/2008
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Series A
Investors
Proceeds Purpose
We intend to use the proceeds of this financing to continue the development of this initial product candidate and to look for additional product opportunities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12555 High Bluff Drive 385
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Meritage Pharma is committed to the development of prescription products based on proven safe and effective molecules to meet the unmet needs of patients and their caregivers. Meritage Pharma's initial product candidate is intended for the treatment of allergic inflammation of the gastrointestinal tract.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elaine Phillips
Chief Scientific Officer
Malcolm Hill
Browse more venture capital transactions:
Prev: 6/16/2008: TeleSphere Networks venture capital transaction
Next: 6/16/2008: Cameron Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs